Photos from Envato
However, treatments are still limited due to the high cost.
Obesity drug sales are expected to reach $173.5B in seven major markets (7mm) by 2031, according to GlobalData.
The expansion of the department is attributed to increased patient awareness and growing physician adoption of medications.
GlobalData pharmaceutical analyst Costanza Alciati said therapies are still restricted due to their high costs.
More than 200 million people currently live in obesity at 7mm, with these figures growing at an annual rate of 0.7% over the forecast period.
“Many promising new drugs are expected to enter the market in the coming years. This will not only continue to revolutionize the obesity space, but will continue to revolutionize the entire cardiometic disease sector,” Alciati added.
7mm = us, France, Germany, Italy, Spain, Britain and Japan.
Join the Healthcare Asia Magazine Community
Since you're here…
…You can promote your company with us and connect with your customers in a variety of ways. Our team can help you Dight and create advertising campaigns on print and digitally on this website and on print magazines.
We can also organize real-life or digital events for you and find thought leader speakers and industry leaders who can become your potential partners to attend. We also run a number of award programs that give you the opportunity to earn your achievements this year, and you can join as a participant or sponsor.
Let us help you move your business forward with a good partnership!
